Last edition
News about "Pharmexcil "
Pharmexcil’s iPHEX 2026 records USD 4.5-5 billion in potential business discussions, attracting buyers from 128 countries, with the next edition set for 2027.
Pharmexcil | 11/09/2026 | By News Bureau | 244
Pharmexcil Eyes USD 1.4 Billion Pharma Exports as iPHEX 2026 Opens New Global Markets
600+ overseas business delegates to engage with Indian pharma companies as Pharmexcil looks to translate global buyer participation into new markets and commercial opportunities.
Pharmexcil | 04/09/2026 | By News Bureau | 132
Central Bureau of Narcotics (CBN) and Pharmexcil sign an MoU to strengthen regulation of controlled substances in pharma exports through a voluntary industry code of conduct.
Pharmexcil | 26/08/2026 | By News Bureau | 113
India to Build Future-Ready Drug Regulatory Framework: J P Nadda
India will build a future-ready drug regulatory framework, with the Central Drugs Standard Control Organisation (CDSCO) set to launch an end-to-end digital regulatory platform within 18 months.
Pharmexcil | 01/08/2026 | By News Bureau | 126
India-UK FTA to Boost Pharma Exports Beyond USD 981 Million in FY2026-27: Pharmexcil
India-UK FTA is expected to boost India's pharmaceutical exports to the UK beyond USD 981 million in FY2026-27, building on strong export growth, according to Pharmexcil.
Pharmexcil | 16/07/2026 | By News Bureau | 121
Pharmexcil and Department of Commerce Hold Regional Outreach Program in Mumbai
The Department of Commerce hosted a Regional Outreach Program and press interaction at Pharmexcil’s Mumbai office, highlighting the growth and achievements of India’s pharmaceutical exports over the past 12 years.
Pharmexcil | 11/06/2026 | By News Bureau | 125
PHARMEXCIL Engages Government Leaders to Strengthen Indian Pharmaceutical Export Growth
The Pharmaceuticals Export Promotion Council of India (PHARMEXCIL) held a series of high-level discussions with key government stakeholders to align policy priorities, accelerate export momentum and reinforce India’s position in global pharmaceutical markets.
Pharmexcil | 06/01/2026 | By News Bureau | 453
India’s pharmaceutical export industry is preparing for 2026 with a sharp focus on quality excellence, regulatory compliance and diversification into new global markets, according to the Pharmaceuticals Export Promotion Council of India (Pharmexcil).
Pharmexcil | 02/01/2026 | By Darshana | 426
Pharmexcil Calls for GST Parity on APIs and Formulations to Boost Pharma Efficiency
The Pharmaceuticals Export Promotion Council of India (Pharmexcil) has called for harmonising GST rates on both active pharmaceutical ingredients (APIs) and finished formulations to streamline compliance and ease financial strain.
Pharmexcil | 26/08/2025 | By Darshana | 410
Pharmexcil, USP Discuss Collaboration on Biosimilar Accessibility, Building Resilient Supply Chain
This discussion between Pharmaceuticals Export Promotion Council of India (Pharmexcil) and United States Pharmacopoeia (USP) happened during the United States Pharmacopoeial (USP) Convention-2025 held recently, which brought together representatives from across the health and science ecosystem to launch the 2025–2030 cycle.
Pharmexcil | 30/06/2025 | By Darshana | 261
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy